The FDA has granted Fast Track and QIPD designations to CMTX-101 for the treatment of CF in patients affected by chronic bacterial pulmonary infections.

"At present, no other class of materials exists with fluoropolymers' unique combined properties including lubricity, ...

CMTX-101 is an investigational immune-enabling antibody designed to target and destroy the pro-inflammatory structure of bacteria biofilms.

The US Food and Drug Administration (FDA) has granted fast track designation to ateganosine (THIO, 6-thio-dG or 6-thio-2’-deoxyguanosine) for the treatment of non-small cell lung cancer (NSCLC).

Innovent Biologics receives US FDA clearance to initiate phase 1 clinical trial of novel oral GLP-1R agonist, IBI3032: San Francisco Wednesday, August 6, 2025, 14:00 Hrs [IST] Inn ...

The company's GAAP revenue of $5.3 million missed analyst expectations of $6.65 million, while the net loss per share (GAAP) was ($0.85), compared to the anticipated ($0.82). Revenue (GAAP) fell ...

Indonesia's National Nutrition Agency (BGN) is ramping up training for food handlers to optimize services at kitchens — ...

Clarametyx Biosciences announced that CMTX-101, a monoclonal antibody designed to collapse bacterial biofilms, will receive ...

Clinical data and cost-effectiveness analysis demonstrates the VenoValve would provide both better health outcomes and lower costs compared to current standard of care treatments ...

As the American population gets older, chronic and rare diseases are becoming a significant healthcare issue, particularly ...

Rep. Bobby Scott (D-Va.) is urging HHS to explain how the recent layoffs of thousands of federal employees are impacting the agency’s mission.

The Association of Community Pharmacists of Nigeria, ACPN, has called on the Federal Government to jettison the controversial National Health Facilities Regulatory Authority, NHFRA, Bill, describing ...